Lymphomatoid Granulomatosis Workup

  • Author: Nader Kamangar, MD, FACP, FCCP, FCCM; Chief Editor: Zab Mosenifar, MD   more...
 
Updated: Jan 18, 2012
 

Laboratory Studies

  • No characteristic laboratory abnormalities exist in lymphomatoid granulomatosis.
  • Obtain a WBC count.
    • Leukopenia (20%) and lymphopenia (33%) may be present.
    • CD4 lymphocyte count may be low.
    • Leukocytosis greater than 10,000 cells/μ L is rare.
  • Hematocrit is normal or slightly elevated.
  • Erythrocyte sedimentation rate (ESR) has mild-to-moderate elevation but may be normal.
  • Obtain renal and liver function studies. Findings are usually normal.
  • Urinalysis results are usually normal.
  • Delayed-type hypersensitivity and lack of anergy have been reported in more than 50% of cases.
Next

Imaging Studies

Obtain chest radiographs. Results are usually abnormal but nonspecific. The radiologic differential diagnosis for lymphomatoid granulomatosis includes pseudolymphoma, malignant lymphoma, lymphocytic interstitial pneumonia, metastasis, sarcoidosis, Wegener granulomatosis, and cryptogenic organizing pneumonia. Some lesions regress, while others progress. Chest radiograph lesions and abnormalities include the following:

  • Bilateral nodules or masses in the lower and peripheral lung fields (80-100%). These nodules may occasionally be migratory in nature.
  • Pleural effusions (33%)
  • Pneumonitis or large masslike lesion (30%)
  • Cavitation of nodules (30%)
  • Pneumothorax (5%)

See the image below.

Chest radiograph showing a dense, large, right uppChest radiograph showing a dense, large, right upper lobe masslike infiltrate and bilateral nodular disease.

Hilar and mediastinal lymphadenopathy are rare and should prompt consideration of an alternative diagnosis or raise concern of transformation into aggressive lymphoma. Airway disease can involve the following:

  • Distal small airway
  • Main bronchial disease (occasionally)
  • Atelectasis or lobar collapse on chest films

Radiographic differential diagnoses can include the following:

  • Primary pulmonary and metastatic malignancy
  • Granulomatous diseases, including WG and sarcoidosis
  • Eosinophilic granulomatosis
  • Amyloidosis

Perform a chest CT scan. The role of CT scan requires further study. CT scan better defines pulmonary lesions, but findings are nonspecific. CT scan is useful for monitoring disease progression and response to treatment.

See the images below.

Contrast-enhanced chest CT scan showing poorly defContrast-enhanced chest CT scan showing poorly defined nodular peribronchovascular infiltrates with air-bronchograms. Contrast-enhanced chest CT scan showing poorly defContrast-enhanced chest CT scan showing poorly defined nodular peribronchovascular infiltrates with air-bronchograms.

Perform brain imaging. CT scan shows high-density lesions. MRI lesions are isointense or hyperintense on T1-weighted images and hyperintense on T2-weighted images. Enhancement may be punctate and linear, a finding that can be relatively specific for inflammation of deep cerebral vessels.

Previous
Next

Procedures

  • Perform a tissue diagnosis.
    • In general, perform a biopsy on the most accessible organ involved.
    • Establishing the diagnosis of lymphomatoid granulomatosis usually requires an open lung or video-assisted thoracoscopic biopsy. Transbronchial lung biopsy has not been studied rigorously. Because of the focal nature of lymphomatoid granulomatosis and the fact that it is not bronchocentric, a low diagnostic yield with bronchoscopic transbronchial biopsies is likely. In one study, the diagnosis was established with the aid of open lung biopsy in 70% of cases, bronchoscopic lung biopsy in 15% of cases, and extrapulmonary biopsy in 15% of cases. In cases where bronchoscopic lung biopsy is nondiagnostic, a thoracoscopic lung biopsy may be necessary.
    • Skin biopsy is the least invasive.
    • In all cases, inform the pathologist that lymphomatoid granulomatosis is clinically suspected to ensure that appropriate studies are performed.
Previous
Next

Histologic Findings

A definitive diagnosis of lymphomatoid granulomatosis requires the presence of the following histological triad:

  • Polymorphic lymphocytic infiltrate
  • Angiitis
  • Granulomatosis (central necrosis)

A nodular perivascular infiltrate containing plasma cells, lymphocytes, and large atypical mononuclear cells in various stages of maturity is present. This is a destructive lesion due to vessel occlusion by lymphocytic infiltration and subsequent tissue necrosis.

Perform analysis for cell phenotype, clonality, and EBV infection. As discussed above, despite the predominance of T cells, the malignant cells appear to be B cells, and the T-cell infiltrate is polyclonal (see Pathophysiology). In general, the B-cell population is clonally expanded; however, oligoclonal populations have been identified in rare cases. A similar finding is described in posttransplant lymphoma and probably reflects an EBV-related phenomenon.

When peripheral nerve involvement exists, the infiltrate surrounds the nerve and causes spotty demyelination.

Previous
 
 
Contributor Information and Disclosures
Author

Nader Kamangar, MD, FACP, FCCP, FCCM  Associate Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of California, Los Angeles, David Geffen School of Medicine, Olive View-UCLA Medical Center; Associate Program Director, Pulmonary and Critical Care Multi-Campus Fellowship Program, Cedars-Sinai/West Los Angeles Veterans Affairs/Los Angeles Kaiser Permanente/Olive View-UCLA Medical Center; Site Director, Pulmonary/Critical Care Fellowship Program, Olive View-UCLA Medical Center

Nader Kamangar, MD, FACP, FCCP, FCCM is a member of the following medical societies: American Academy of Sleep Medicine, American Association of Bronchology, American College of Chest Physicians, American College of Physicians, American Lung Association, American Medical Association, American Thoracic Society, California Thoracic Society, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Anthony W O'Regan, MD  Clinical Lecturer of Medicine, Department of Internal Medicine, Section of Respiratory Medicine, National University of Ireland, Galway; Adjunct Professor of Medicine, Boston University Medical Center

Disclosure: Nothing to disclose.

Specialty Editor Board

Ryland P Byrd Jr, MD  Professor, Department of Internal Medicine, Division of Pulmonary Medicine and Critical Care Medicine, Program Director of Pulmonary Diseases and Critical Care Medicine Fellowship, East Tennessee State University, James H Quillen College of Medicine; Medical Director of Respiratory Therapy, James H Quillen Veterans Affairs Medical Center

Ryland P Byrd Jr, MD is a member of the following medical societies: American College of Chest Physicians and American Thoracic Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Timothy D Rice, MD  Associate Professor, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, St Louis University School of Medicine

Timothy D Rice, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Physicians

Disclosure: Nothing to disclose.

Chief Editor

Zab Mosenifar, MD  Director, Division of Pulmonary and Critical Care Medicine, Director, Women's Guild Pulmonary Disease Institute, Professor and Executive Vice Chair, Department of Medicine, Cedars Sinai Medical Center, University of California, Los Angeles, David Geffen School of Medicine

Zab Mosenifar, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, and American Thoracic Society

Disclosure: Nothing to disclose.

References
  1. Liebow AA, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol. Dec 1972;3(4):457-558. [Medline].

  2. Araki F, Mimura T, Fukuoka S, et al. Primary orbital lymphomatoid granulomatosis. Br J Ophthalmol. Apr 2009;93(4):554-6. [Medline].

  3. Pereira AC, Oliveira TM, Nomelini RS, Saldanha JC, Calil MC, Murta EF. Lymphomatoid granulomatosis of the vulva: case report with immunohistochemical analysis. J Obstet Gynaecol. Apr 2009;29(3):255-6. [Medline].

  4. Canovas D, Vinas J, Martinez J, Viguera M, Estela J, Ribera G. [Lymphomatoid granulomatosis with exclusively neurological involvement.]. Neurologia. Mar 2009;24(2):140-1. [Medline].

  5. Lucantoni C, De Bonis P, Doglietto F, et al. Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review. J Neurooncol. Mar 26 2009;[Medline].

  6. Lemieux J, Bernier V, Martel N, Delage R. Autologous hematopoietic stem cell transplantation for refractory lymphomatoid granulomatosis. Hematology. Dec 2002;7(6):355-8. [Medline].

  7. Rao R, Vugman G, Leslie WT, Loew J, Venugopal P. Lymphomatoid granulomatosis treated with rituximab and chemotherapy. Clin Adv Hematol Oncol. Nov 2003;1(11):658-60; discussion 660. [Medline].

  8. Wilson WH, Kingma DW, Raffeld M, Wittes RE, Jaffe ES. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood. Jun 1 1996;87(11):4531-7. [Medline].

  9. Polizzotto MN, Dawson MA, Opat SS. Failure of rituximab monotherapy in lymphomatoid granulomatosis. Eur J Haematol. Aug 2005;75(2):172-3. [Medline].

  10. Castrale C, El Haggan W, Chapon F, Reman O, Lobbedez T, Ryckelynck JP, et al. Lymphomatoid granulomatosis treated successfully with rituximab in a renal transplant patient. J Transplant. 2011;2011:865957. [Medline]. [Full Text].

  11. Jordan K, Grothey A, Grothe W, Kegel T, Wolf HH, Schmoll HJ. Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy. Eur J Haematol. Mar 2005;74(3):263-6. [Medline].

  12. Sebire NJ, Haselden S, Malone M, Davies EG, Ramsay AD. Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy. J Clin Pathol. Jul 2003;56(7):555-7. [Medline].

  13. Zaidi A, Kampalath B, Peltier WL, Vesole DH. Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab. Leuk Lymphoma. Apr 2004;45(4):777-80. [Medline].

  14. Jaffre S, Jardin F, Dominique S, Duet E, Hubscher P, Genevois A. Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab. Eur Respir J. Mar 2006;27(3):644-6. [Medline].

  15. Ishiura H, Morikawa M, Hamada M, Watanabe T, Kako S, Chiba S, et al. Lymphomatoid granulomatosis involving central nervous system successfully treated with rituximab alone. Arch Neurol. May 2008;65(5):662-5. [Medline].

  16. Bolaman Z, Kadiköylü G, Polatli M, Barutca S, Culhaci N, Sentürk T. Migratory nodules in the lung: lymphomatoid granulomatosis. Leuk Lymphoma. Jan 2003;44(1):197-200. [Medline].

  17. Chung JH, Wu CC, Gilman MD, Palmer EL, Hasserjian RP, Shepard JA. Lymphomatoid granulomatosis: CT and FDG-PET findings. Korean J Radiol. Nov 2011;12(6):671-8. [Medline]. [Full Text].

  18. Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer. Jan 1979;43(1):360-73. [Medline].

  19. McNiff JM, Cooper D, Howe G, Crotty PL, Tallini G, Crouch J, et al. Lymphomatoid granulomatosis of the skin and lung. An angiocentric T-cell-rich B-cell lymphoproliferative disorder. Arch Dermatol. Dec 1996;132(12):1464-70. [Medline].

  20. Myers JL. Lymphomatoid granulomatosis: past, present, ... future?. Mayo Clin Proc. Feb 1990;65(2):274-8. [Medline].

  21. Wu SM, Min Y, Ostrzega N, Clements PJ, Wong AL. Lymphomatoid granulomatosis: a rare mimicker of vasculitis. J Rheumatol. Nov 2005;32(11):2242-5. [Medline].

Previous
Next
 
Chest radiograph showing a dense, large, right upper lobe masslike infiltrate and bilateral nodular disease.
Contrast-enhanced chest CT scan showing poorly defined nodular peribronchovascular infiltrates with air-bronchograms.
Contrast-enhanced chest CT scan showing poorly defined nodular peribronchovascular infiltrates with air-bronchograms.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.